Cyra-LS Tablet is a prescription gastrointestinal medicine formulated with rabeprazole 20 mg and levosulpiride 75 mg. This combination is marketed for conditions involving excessive stomach acid, acid reflux, and problems with gastrointestinal movement. Available product information identifies Systopic Laboratories as the marketer and describes the medicine as an oral prescription product.

If heartburn, acid regurgitation, bloating, early fullness, or indigestion regularly interferes with meals and daily activities, your healthcare professional may consider a combination such as Cyra-LS Tablet when both acid suppression and improved gastric motility are appropriate. It does not simply mask symptoms; its two active ingredients address different contributors to upper gastrointestinal discomfort. However, patients should understand that the medicine controls symptoms and treats certain acid-related conditions rather than guaranteeing a permanent cure.

What Does Cyra-LS Tablet Contain?

Cyra-LS Tablet contains rabeprazole, a proton pump inhibitor (PPI), together with levosulpiride, a medicine with prokinetic activity. Current medicine references list the strength as rabeprazole 20 mg plus levosulpiride 75 mg.

Rabeprazole decreases the amount of acid produced by the stomach. This action can reduce irritation caused by excess gastric acid and can support the healing of acid-related damage. Rabeprazole belongs to the proton pump inhibitor class; FDA records also identify rabeprazole as a PPI, and U.S. labeling for rabeprazole describes approved uses involving GERD and certain ulcers.

Levosulpiride works differently. It has prokinetic effects that can improve movement through the upper digestive tract. By helping stomach contents move forward, it may reduce symptoms associated with delayed gastric emptying, including uncomfortable fullness, bloating, and some forms of indigestion.

Uses and Potential Benefits

Doctors may prescribe Cyra-LS Tablet for gastroesophageal reflux disease (GERD), acid reflux, and functional digestive symptoms. Available product references also describe its use in certain ulcer-related and intestinal conditions.

For people with GERD, stomach acid can travel backward into the esophagus and produce burning discomfort, sour regurgitation, or irritation. The rabeprazole component reduces gastric acid production, while levosulpiride may support gastrointestinal movement. Together, these actions can provide a broader approach when a healthcare professional determines that the combination is suitable.

Cyra-LS Tablet may also help people experiencing indigestion associated with bloating, post-meal fullness, nausea, or uncomfortable stomach sensations. Nevertheless, persistent symptoms deserve medical evaluation because reflux-like symptoms can sometimes arise from conditions that require a different treatment.

How to Take Cyra-LS Tablet

Take Cyra-LS Tablet exactly as your prescriber directs. Product information commonly recommends taking the tablet before food, with one reference specifically advising approximately one hour before a meal.

Swallow the tablet whole with water. Do not crush, chew, or break it unless your pharmacist or physician specifically instructs you to do so. Take each dose at the prescribed time and do not increase the dose because symptoms have not improved immediately.

If you forget a dose, take it when you remember unless it is nearly time for your next scheduled dose. Avoid taking two doses together to compensate for a missed dose.

Related Product

Possible Side Effects

Like every prescription medicine, Cyra-LS Tablet can cause side effects. Reported effects can include headache, dizziness, weakness, cough, and stomach discomfort.

Levosulpiride may cause dizziness or drowsiness in some individuals. If you feel impaired, avoid driving, cycling, or operating machinery until you know how the medicine affects you. Product information specifically advises caution with driving when dizziness or drowsiness occurs.

Seek prompt medical advice if you develop severe or unusual symptoms, persistent vomiting, significant abdominal pain, allergic reactions, fainting, abnormal movements, or other concerning effects.

Important Safety Information

Do not start Cyra-LS Tablet without medical advice simply because you experience occasional heartburn. A healthcare professional should determine the underlying cause and whether this combination is appropriate.

Tell your doctor if you have liver or kidney problems, gastrointestinal bleeding, an intestinal obstruction, neurological disorders, heart rhythm problems, or other significant medical conditions. Also provide a complete list of prescription medicines, over-the-counter products, and supplements you use.

Pregnant or breastfeeding patients should consult a healthcare professional before taking this medicine because the safety of the combination requires individualized assessment.

Long-term or inappropriate acid-suppressing therapy should not continue without medical supervision. Your clinician can determine the appropriate duration based on your diagnosis and response.

Food and Lifestyle Measures

Medicine works best when you also address habits that trigger reflux. Eat smaller meals when appropriate, avoid lying down immediately after eating, and identify foods that consistently worsen your symptoms. Limiting very fatty or spicy meals may help some individuals. Maintaining a healthy weight, avoiding tobacco, and moderating alcohol intake can also support reflux management.

Raise the upper part of your body during sleep if nighttime reflux affects you. If symptoms continue despite treatment, speak with your healthcare professional rather than repeatedly increasing medication on your own.

Cyra-LS Tablet and U.S. Regulatory Considerations

Patients ordering medicines internationally should verify the product, manufacturer, active ingredients, strength, and prescription requirements before purchasing. FDA maintains Drugs@FDA as a resource for checking medicines approved for sale in the United States.

Importantly, the presence of levosulpiride in FDA substance databases does not itself mean that a particular product has FDA approval; FDA explicitly notes that a substance record does not imply regulatory review or approval. Therefore, U.S. patients should ask a licensed U.S. healthcare professional or pharmacist whether this specific product is appropriate and legally available for their situation.

Related Keywords

Useful related search terms include Cyra-LS uses, Cyra-LS composition, Cyra-LS dosage, Cyra-LS side effects, rabeprazole and levosulpiride, acid reflux medicine, GERD treatment, heartburn treatment, indigestion medicine, and prokinetic medicine.

Frequently Asked Questions

1. What is Cyra-LS Tablet used for?

Cyra-LS Tablet is used under medical supervision for GERD, acid reflux, and certain digestive symptoms. Product references also list applications involving ulcers and intestinal conditions.

2. How does Cyra-LS Tablet work?

It combines rabeprazole, which reduces stomach acid, with levosulpiride, which has prokinetic activity and can improve upper gastrointestinal movement.

3. Can Cyra-LS Tablet permanently cure GERD?

Not necessarily. GERD often requires ongoing lifestyle management and individualized medical treatment. This medicine can control symptoms and treat acid-related disease when appropriately prescribed, but it does not guarantee a permanent cure.

4. When should I take Cyra-LS Tablet?

Follow your prescription. Product information commonly recommends taking it before food, with one reference specifying about one hour before eating.

5. Can Cyra-LS Tablet cause dizziness?

Yes. Dizziness has been reported. Avoid driving or operating machinery if you feel dizzy or drowsy.